March 26, 2020 / 9:50 PM / 14 days ago

BRIEF-Moleculin Biotech - Received A Deficiency Letter From Listing Qualifications Department Of Nasdaq

March 26 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN BIOTECH INC - RECEIVED A DEFICIENCY LETTER FROM LISTING QUALIFICATIONS DEPARTMENT OF NASDAQ Source text: (bit.ly/2WJFXLi) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below